Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,212,324 papers from all fields of science
Search
Sign In
Create Free Account
ANRIL long non-coding RNA, human
Known as:
CDKN2B-AS long non-coding RNA, human
, CDKN2B antisense RNA, human
, antisense noncoding RNA in the INK4 locus, human
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
RNA, Long Untranslated
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Long non‐coding RNA ANRIL enhances mitochondrial function of hepatocellular carcinoma by regulating the MiR‐199a‐5p/ARL2 axis
Kun Li
,
Bao Zhao
,
+4 authors
Guodong Liu
Environmental Toxicology
2020
Corpus ID: 204970410
Although the roles of long non‐coding RNA (lncRNA) ANRIL (Antisense non‐coding RNA in the INK4A locus) have been established in…
Expand
2019
2019
Effects of lncRNA ANRIL on proliferation and apoptosis of oral squamous cell carcinoma cells by regulating TGF-β/Smad pathway.
L. Liu
,
S. Ning
,
S. Fu
,
Y. Mao
,
M. Xiao
,
B. Guo
European Review for Medical and Pharmacological…
2019
Corpus ID: 198997864
OBJECTIVE To investigate the role of the long non-coding ribonucleic acid (lncRNA) antisense non-coding RNA in the INK4 locus…
Expand
Highly Cited
2018
Highly Cited
2018
The interplay of LncRNA ANRIL and miR‐181b on the inflammation‐relevant coronary artery disease through mediating NF‐κB signalling pathway
Feng Guo
,
Chengchun Tang
,
+4 authors
Y. Mu
Journal of Cellular and Molecular Medicine
2018
Corpus ID: 51920756
This study was designed to investigate whether ANRIL affected the aetiology of coronary artery disease (CAD) by acting on…
Expand
2018
2018
长链非编码RNA-ANRIL rs2383207多态性与缺血性脑卒中发病风险的Meta分析
何发毅
,
刘伟
,
+4 authors
柳华
2018
Corpus ID: 187535939
Highly Cited
2017
Highly Cited
2017
A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
Man Liu
,
Lu-qi Xing
,
Yi-jing Liu
Medicine
2017
Corpus ID: 18056066
Background: Triple-negative breast cancer (TNBC) is an aggressive cancer with unfavorable outcome and it is useful to explore…
Expand
Highly Cited
2017
Highly Cited
2017
Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer
Wei-jing Gong
,
Jing-bo Peng
,
+9 authors
Zhaoqian Liu
Acta Pharmacologica Sinica
2017
Corpus ID: 1024547
Platinum-based chemotherapy is the standard first-line treatment for most lung cancer patients. However, the toxicity induced by…
Expand
Highly Cited
2016
Highly Cited
2016
Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway
Xiao Zhou
,
Xiaorui Han
,
+6 authors
Zicai Liang
RNA Biology
2016
Corpus ID: 10960268
ABSTRACT Antisense Noncoding RNA in the INK4 Locus (ANRIL) is the prime candidate gene at Chr9p21, the well-defined genetic risk…
Expand
2016
2016
ANRIL rs2383207 polymorphism and coronary artery disease (CAD) risk: a meta-analysis with observational studies.
P. Wang
,
P. Dong
,
X. Yang
Cellular and Molecular Biology
2016
Corpus ID: 9525953
Some studies investigated the association of antisense non-coding RNA in the INK4 locus (ANRIL) rs2383207 polymorphism with…
Expand
2016
2016
Abstract 999: P16 DNA methylation inactivates transcription of IncRNA ANRIL
Ying Gan
,
Baozhen Zhang
,
C. Cui
,
D. Deng
2016
Corpus ID: 58360498
The exonic ANRIL (P15AS) is a 3.8-kb lncRNA transcribed from the antisense strand of the P14 promoter and flanking regions…
Expand
Highly Cited
2011
Highly Cited
2011
Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
L. Holdt
,
K. Sass
,
G. Gäbel
,
H. Bergert
,
J. Thiery
,
D. Teupser
Atherosclerosis
2011
Corpus ID: 24831235
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE